Total Payments
$9,228
2024 Payments
$2,169
Companies
43
Transactions
166
Medicare Patients
790
Medicare Billing
$80,936
Payment Breakdown by Category
Food & Beverage$9,228 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,228 | 166 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,338 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,175 | 20 | $0 (2024) |
| Gilead Sciences, Inc. | $495.51 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $490.83 | 20 | $0 (2023) |
| Amgen Inc. | $469.66 | 16 | $0 (2024) |
| United Therapeutics Corporation | $320.53 | 3 | $0 (2024) |
| Abbott Laboratories | $306.92 | 6 | $0 (2024) |
| Grifols USA, LLC | $279.50 | 3 | $0 (2023) |
| Incyte Corporation | $250.41 | 2 | $0 (2022) |
| Lucid Diagnostics Inc. | $243.93 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,169 | 41 | AstraZeneca Pharmaceuticals LP ($477.13) |
| 2023 | $1,875 | 31 | Astellas Pharma US Inc ($183.63) |
| 2022 | $2,783 | 41 | ABBVIE INC. ($410.84) |
| 2021 | $2,401 | 53 | AstraZeneca Pharmaceuticals LP ($396.70) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Insomnia | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $77.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: HCV | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $104.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $133.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $118.75 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $121.96 | General |
| Category: INFLAM | ||||||
| 09/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.79 | General |
| Category: Cardio-renal | ||||||
| 09/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $119.84 | General |
| Category: Diabetes Care | ||||||
| 07/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Inflammation | ||||||
| 07/12/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $98.79 | General |
| 07/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes Care | ||||||
| 07/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardio-renal | ||||||
| 07/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: Cardio-renal | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Inflammation | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.72 | General |
| 06/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Cardio-renal | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $57.12 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 177 | 312 | $56,670 | $19,885 |
| 2022 | 4 | 194 | 357 | $66,860 | $23,793 |
| 2021 | 9 | 381 | 597 | $94,260 | $35,287 |
| 2020 | 2 | 38 | 39 | $5,100 | $1,971 |
Total Patients
790
Total Services
1,305
Medicare Billing
$80,936
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 258 | $51,600 | $17,614 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $3,150 | $1,522 | 48.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 20 | 20 | $1,120 | $437.00 | 39.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $800.00 | $311.00 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 295 | $59,000 | $21,424 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $5,980 | $1,607 | 26.9% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 20 | 20 | $1,120 | $456.16 | 40.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 19 | 19 | $760.00 | $305.62 | 40.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 156 | 332 | $66,400 | $24,716 | 37.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $5,980 | $2,287 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $4,275 | $2,189 | 51.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 14 | 14 | $4,900 | $2,041 | 41.7% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 55 | 87 | $4,350 | $1,349 | 31.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2021 | 40 | 40 | $2,240 | $930.42 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 21 | $3,675 | $805.01 | 21.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 41 | 41 | $1,640 | $654.14 | 39.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 20 | 20 | $800.00 | $314.99 | 39.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 21 | $4,200 | $1,587 | 37.8% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 18 | 18 | $900.00 | $383.76 | 42.6% |
About Daniel Sam Acierto
Daniel Sam Acierto is a Family healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2020. The National Provider Identifier (NPI) number assigned to this provider is 1528670866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Sam Acierto has received a total of $9,228 in payments from pharmaceutical and medical device companies, with $2,169 received in 2024. These payments were reported across 166 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($9,228).
As a Medicare-enrolled provider, Acierto has provided services to 790 Medicare beneficiaries, totaling 1,305 services with total Medicare billing of $80,936. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Henderson, NV
- Active Since 08/18/2020
- Last Updated 07/11/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1528670866
Products in Payments
- UBRELVY (Drug) $458.33
- VRAYLAR (Drug) $432.04
- XIFAXAN (Drug) $391.69
- FARXIGA (Drug) $374.76
- Repatha (Biological) $297.98
- Prolastin-C Liquid (Biological) $279.50
- BREZTRI (Drug) $261.85
- FREESTYLE LIBRE 3 (Device) $261.57
- NURTEC ODT (Drug) $254.16
- TYVASO (Drug) $221.74
- QULIPTA (Drug) $221.28
- Veozah (Drug) $211.88
- QUVIVIQ (Drug) $185.08
- Kerendia (Drug) $183.42
- Ozempic (Drug) $157.98
- AIRSUPRA (Drug) $157.25
- WATCHMAN Access System (Device) $149.77
- Otezla (Drug) $145.58
- Da Vinci Surgical System (Device) $140.36
- VOQUEZNA (Drug) $133.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Henderson
Kristy Solis
Family — Payments: $20,297
Family $20,297
Joseph Lau, Aprn, APRN
Family — Payments: $13,615
Family $13,615
Judith Yu, Aprn, APRN
Family — Payments: $11,118
Family $11,118
Tad Titlow, Apn-C, APN-C
Family — Payments: $8,391
Family $8,391
Jackie Armijo, Fnp, FNP
Family — Payments: $8,206
Family $8,206
Michael Colotta, Fnp-C, FNP-C
Family — Payments: $6,904
Family $6,904